Authors’ Reply to Mintz: “Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model”
Sign Up to like & getrecommendations! Published in 2019 at "Applied Health Economics and Health Policy"
DOI: 10.1007/s40258-018-00459-y
Abstract: We appreciate the detailed comments provided by Dr. Paul Mintz regarding our paper “Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model [1].” To provide a brief context,… read more here.
Keywords: components hospital; platelet components; impact; paper ... See more keywords
Differential protein expression of blood platelet components associated with adverse transfusion reactions.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of proteomics"
DOI: 10.1016/j.jprot.2018.12.019
Abstract: Platelets found within platelet components (PCs) intended for transfusion release inflammatory molecules. Despite the implementation of leukoreduction, some of these PCs are occasionally associated with adverse transfusion reactions (ATRs). The aim of this study was… read more here.
Keywords: sda pcs; transfusion reactions; platelet components; transfusion ... See more keywords
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components
Sign Up to like & getrecommendations! Published in 2022 at "Transfusion"
DOI: 10.1111/trf.16987
Abstract: Platelet transfusion carries risk of transfusion‐transmitted infection (TTI). Pathogen reduction of platelet components (PRPC) is designed to reduce TTI. Pulmonary adverse events (AEs), including transfusion‐related acute lung injury and acute respiratory distress syndrome (ARDS) occur… read more here.
Keywords: platelet; platelet components; pulmonary adverse; risk ... See more keywords
Residual risks of bacterial contamination for pathogen‐reduced platelet components
Sign Up to like & getrecommendations! Published in 2022 at "Vox Sanguinis"
DOI: 10.1111/vox.13272
Abstract: Platelet components are commonly transfused to patients for a variety of indications, including patients with low platelet counts or patients with platelet dysfunction who are bleeding or at high risk of bleeding. Although the risk… read more here.
Keywords: risks bacterial; platelet components; contamination; residual risks ... See more keywords